Raajit Rampal, MD

Implications of Mutation Profiling in Myeloid Malignancies—PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies

May 15, 2018

Kelsey Sokol, MD
Douglas Tremblay, MD
Sheena Bhalla, MD
Raajit Rampal, MD
John O. Mascarenhas, MD

In this second part of our two-part review, we discuss the use of mutation profiling in the diagnosis, prognosis, and treatment of patients with myeloproliferative neoplasms and other myeloid diseases.

READ >>

Implications of Mutation Profiling in Myeloid Malignancies—PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia

April 15, 2018

Douglas Tremblay, MD
Kelsey Sokol, MD
Sheena Bhalla, MD
Raajit Rampal, MD
John O. Mascarenhas, MD

In this first part of our two-part review, we introduce mutation profiling as a relevant clinical tool for hematologists treating patients with myeloid malignancies.

READ >>